# EDGAR Filing Document

**Accession Number:** 0001621221
**File Stem:** 0001640334-25-001219
**Filing Date:** 2025-7
**Character Count:** 2757
**Document Hash:** fef79f12e8b630de354901f64e4ca7ac
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001640334-25-001219.hdr.sgml**: 20250814

**ACCESSION NUMBER**: 0001640334-25-001219

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20250716

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** ARTELO BIOSCIENCES, INC.
- **CENTRAL INDEX KEY:** 0001621221
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 331220924
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 505 LOMAS SANTA FE, SUITE 160
- **CITY:** SOLANA BEACH
- **STATE:** CA
- **ZIP:** 92075
- **BUSINESS PHONE:** 858-925-7049

**MAIL ADDRESS:**
- **STREET 1:** 505 LOMAS SANTA FE, SUITE 160
- **CITY:** SOLANA BEACH
- **STATE:** CA
- **ZIP:** 92075

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** REACTIVE MEDICAL INC.
- **DATE OF NAME CHANGE:** 20170207

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** KNIGHT KNOX DEVELOPMENT CORP.
- **DATE OF NAME CHANGE:** 20141001

July 16, 2025

**<u>VIA EDGAR</u>**

U.S. Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

100 F Street, N.E.

Washington, D.C. 20549-3720

Attention: Doris Stacey Gama

---

| | |
|:---|:---|
| **Re:** | **Artelo Biosciences Inc.** |
|  | **Registration Statement on Form S-1**<br> **File No. 333-288653** |

---

**Acceleration Request**

---

| | |
|:---|:---|
| **Requested Date:** | **July 17, 2025** |
| **Requested Time:** | **4:00 p.m. Eastern Time, or as soon thereafter as practicable** |

---

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Artelo Biosciences, Inc. (the "**Company**") hereby requests that its Registration Statement on Form S-1 (File No. 333-288653) (the "**Registration Statement**") be declared effective at the "Requested Date" and "Requested Time" set forth above or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Wilson Sonsini Goodrich & Rosati, P.C., by calling Thomas E. Hornish at (858) 209-1020.

---

| | |
|:---|:---|
| Sincerely, | Sincerely, |
| ARTELO BIOSCIENCES, INC. | ARTELO BIOSCIENCES, INC. |
| By: | /s/Gregory D. Gorgas. |
|  | Gregory D. Gorgas. President and Chief Executive Officer |

---

cc: Martin J. Waters, Wilson Sonsini Goodrich & Rosati, P.C. <br> Thomas E. Hornish, Wilson Sonsini Goodrich & Rosati, P.C. Robert Wernli, Wilson Sonsini Goodrich & Rosati, P.C.